Lewes, DE -- (SBWIRE) -- 07/24/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Liberator Medical Holdings, Inc. (OTCBB:LBMH), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), Arch Therapeutics Inc (OTCBB:ARTH), Bullfrog Gold Corp (OTCMKTS:BFGC)
Liberator Medical Holdings, Inc. (OTCBB:LBMH) declined -14.71%, trading on 757,131 shares to end the trade at $1.45. The stock changed hands in a range of $1.33 to $1.69, bringing its market capitalization at about $69.86 million. If we look at its trading history of past 52 weeks, the share price suffered low of $0.56 and was moved to maximum level of $1.90. Liberator Medical Holdings, Inc. and its subsidiaries distribute direct-to-consumer durable medical supplies for seniors in the United States. The company primarily offers urological catheters, ostomy supplies, mastectomy fashions, and diabetic supplies.
Why Should Investors Buy LBMH After the Recent Fall? Just Go Here and Find Out
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) added 1.50% to complete the trading session at $9.32 with a total volume of 110,016 shares. The stock, on average, trades on a volume of 140,878 shares. It floated in a range of $9.15 to $9.32 during last trading session with a beta value of 1.00. Its market capitalization now moved to about $3.46 billion. In the past 52 weeks, the share price has not declined below $8.50 and above $11.53. Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services, information technology (IT) services, and network services in New Zealand and Australia.
Why Should Investors Buy NZTCY After The Recent Gain? Just Go Here and Find Out
Arch Therapeutics Inc (OTCBB:ARTH) added 6% and was in a range of $0.51-$0.55 before closing at $0.530. The stock completed the day with a total volume of 1.86 million shares versus an average volume of 1.75 million shares. The share price hit its 52-week low of $0.01 and $1.36 was the best price. Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding. The company was formerly known as Clear Nano Solutions, Inc. It was founded in 2006 and is based in Natick, Massachusetts.
What was the Moving Force behind ARTH on Bullish Run? Read This Research Report
Bullfrog Gold Corp (OTCMKTS:BFGC) added 26.84% yesterday, bringing its market capitalization around $9.10 million. The share price after opening at $0.19 made a high of $0.26 and hovered above $0.19 to end the day at $0.241. The total number of shares changed hands during the session was 3.79 million shares as compared to average trading volume of 86,925 shares. Bullfrog Gold Corp., a junior exploration company, engages in the acquisition and exploration of gold properties in the United States. It primarily explores for gold and silver ores, as well as zinc, lead, and copper ores.
For How Long BFGC will fight for Profitability? Read This Trend Analysis report
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/